Imunon CEO receives 6,697 shares in place of salary

Imunon, Inc. President and CEO and director Stacy Lindborg acquired 6,697 shares of common stock on September 25, 2026, as stock granted in lieu of cash for a portion of base salary.

Rhea-AI Filing Summary

Imunon, Inc. President and CEO and director Stacy Lindborg acquired 6,697 shares of common stock on September 25, 2026, as stock granted in lieu of cash for a portion of base salary. The reported price was $1.4100 per share. Her direct holdings after the award were 113,197 shares; she also reported 778 shares indirectly held by a 401(k) Plan.

Insider Trade Summary

Grant/Award: 6,697 shares

Grant/Award 2 txns

Insider Lindborg Stacy

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,697	$1.41	$9K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 113,197 shares (Direct); Common Stock — 778 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of base salary

Key Figures

Shares awarded: 6,697 shares Reported price per share: $1.4100 per share Direct shares held after award: 113,197 shares +1 more

4 metrics

Shares awarded 6,697 shares September 25, 2026; granted in lieu of cash for a portion of base salary

Reported price per share $1.4100 per share September 25, 2026 award

Direct shares held after award 113,197 shares September 25, 2026

Shares held indirectly by 401(k) Plan 778 shares September 25, 2026

Key Terms

401(k) Plan, in lieu of cash, Common Stock

3 terms

401(k) Plan financial

"By 401(k) Plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

in lieu of cash financial

"Stock granted in lieu of cash for portion of base salary"

Common Stock financial

"Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did IMNN CEO Stacy Lindborg receive?

Stacy Lindborg, Imunon's President and CEO and a director, received 6,697 shares on September 25, 2026, as stock granted in lieu of cash for a portion of base salary; the reported price was $1.4100 per share.

What were Stacy Lindborg's IMNN holdings after the award?

Her reported direct holdings after the award were 113,197 shares. She also reported 778 shares indirectly held by a 401(k) Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:31 PM Accepted by SEC EDGAR 09/28/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindborg Stacy

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2026		A		6,697(1)	A	$1.41	113,197	D
Common Stock								778	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

	/s/ Jeffrey W Church, Attorney in Fact for Stacy R. Lindborg	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)